nicole fay, PHD
life sciences consultant
Nicole Fay, PhD, Life Sciences Consultant with Juvena Therapeutics since March 2018, is managing the company's in vivo and analytics CRO endeavors. She is also advising on biotechnology preclinical path to IND strategies, quality control, and diligence-related documentation.
Nicole has worked as an independent consultant since 2014, where she advised early stage life sciences companies, VC firms and patent firms as a scientific specialist. In addition to consulting, she was the 2nd employee at Applied Molecular Transport (AMT), a biotechnology start-up focused on targeted oral biological therapeutics. While Nicole was a Senior Scientist/Scientist there, she worked on therapeutics for autoimmune and metabolic diseases, including growth hormone-related disorders.
Prior to AMT, Nicole was at the University of California at Berkeley (UCB), completing a Biotechnology Management of Technology Certification program at Haas Business School, a post-doc in Biophysics, and a Ph.D. in Molecular & Cell Biology. At UCB, Nicole focused on engineering recombinant immuno-modulatory fusion proteins to control ex vivo lymphocyte cellular fate, taking a novel, image analytics-based approach. Nicole's initial research experience began as an undergraduate in 2005 at the Georgia Institute of Technology, where she had the opportunity to work in several labs ranging from a D. rerio neurobiology lab (at Cornell University) to a biophysical lab studying transcytosis. Nicole's research experiences have been captured in publications, presentations at national conferences, and via awards (see links below). Nicole's science outreach has been featured on-line and you can find Nicole as a regular invited speaker on UCB campus.
Since Nicole's initial research experience studying cellular adaptation, she continues to translate molecular signaling events into novel therapeutic programs. In this arena, Nicole knows her work on recombinant protein-based drugs will have the greatest potential to revolutionize modern medicine. While working with the Juvena Therapeutics team, Nicole is happy to to help develop new, regenerative medicines that can repair muscle injury, treat sarcopenia, increase healthspan, and vastly improve quality of life for our elderly population.